Recent Finacing
Recent Raise
Arrakis operates TRYST and PEARL-seq platforms, combining computational models, biophysical/cellular assays and chemical libraries to discover and optimize small-molecule modulators of RNA for oncology, neurology, and rare diseases.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors
